Bottom line
Is VBCB a good fund? The bottom line
VBCB is an index target-date ETF from Vanguard.
It charges 0.08% — about $8 a year on every $10,000 invested, cheaper than 95% of target-date funds we track.
With $46.8 million in net assets and 651 holdings, its largest position is CVS Health Corp (0.7%) and the top 10 make up 6.1% of the portfolio.
What stands out
- Low cost: cheaper than 95% of target-date peers
- Broadly diversified (651 holdings)
What to watch
- Small fund ($46.8 million) — small funds are likelier to close
Updated Nov 19, 2026
What VBCB invests in
Vanguard Target Maturity 2028 Corporate Bond ETF (the Fund) seeks to track the performance of a market-weighted index composed of U.S. dollar-dominated, investment-grade corporate bonds maturing in 2028.
The Fund employs an indexing investment approach designed to track the performance of the ICE 2028 Maturity US Corporate Constrained Index (the Target Index). The Target Index has a planned liquidation on or about December 15, 2028, and includes U.S. dollar-denominated, investment-grade corporate bonds scheduled to mature between January 1, 2028 and December 15, 2028. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the components of the Target Index or in securities determined by the Funds advisor to have economic characteristics substantially identical to those of the Target Index components. The Fund is a term fund that will liquidate on or about December 15, 2028 (the Planned Liquidation Date). The Fund does not seek to return any predetermined amount at liquidation or in periodic…
From the fund's prospectus (filed Mar 23, 2026).
What VBCB costs
On a $10,000 investment, VBCB's 0.08% expense ratio costs about $8 a year. The median target-date fund charges 0.59%.
VBCB top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | CVS Health Corp | 0.72% |
| 2 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.70% |
| 3 | Wells Fargo & Co | 0.63% |
| 4 | Goldman Sachs Bank USA/New York NY | 0.59% |
| 5 | Bank of America Corp | 0.59% |
| 6 | JPMorgan Chase & Co | 0.58% |
| 7 | Bank of America Corp | 0.58% |
| 8 | Morgan Stanley | 0.58% |
| 9 | Goldman Sachs Group Inc/The | 0.56% |
| 10 | Cigna Group/The | 0.56% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 6.1% of the fund. See all top 25 holdings and asset mix →